Details for 2018808912
Up to date per 03.04.2026
Actions
Details for 2018808912
Granted/Registered
European Patent
15.04.2020 A
03.07.2024 B1
31.05.2017
US
201762513257 P
A61K 31/451 20060101AFI20210120BHEP
Owner
Napo Pharmaceuticals, Inc.200 Pine Street, Suite 400 San Francisco, CA 94104US
Representative
No representatives present
Inventor
CONTE, Lisa, A.301 Main St. Apt. 30g San Francisco CA 94105US
CHATURVEDI, Pravin, R.27 Jenkins Rd. Andover MA 01810US
CONTE, Charles161 Elderfields Rd. Manhasset NY 11030US
Information about Fees